Xian F - Search Results

1

Development and Validation of Nomograms to Predict the Overall Survival and Progression-Free Survival in Patients with Advanced Unresectable Intrahepatic Cholangiocarcinoma.

Xian F, Song X, Bie J, Xu G. Xian F, et al. Cancer Manag Res. 2024 Dec 18;16:1835-1849. doi: 10.2147/CMAR.S489960. eCollection 2024. Cancer Manag Res. 2024. PMID: 39713568 Free PMC article.

2

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma.

Zhang G, Yang C, Zhao C, Xian F, Qing D, Guo Q, Song J, Liu X, Bie J. Zhang G, et al. Among authors: xian f. Cancer Manag Res. 2023 Jan 30;15:101-112. doi: 10.2147/CMAR.S395191. eCollection 2023. Cancer Manag Res. 2023. PMID: 36743459 Free PMC article.

3

Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis.

Xian F, Wu C, Zhang G, Xu G. Xian F, et al. Medicine (Baltimore). 2022 Nov 4;101(44):e31479. doi: 10.1097/MD.0000000000031479. Medicine (Baltimore). 2022. PMID: 36343054 Free PMC article.

4

Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis.

Xian F, Yang X, Xu G. Xian F, et al. Front Oncol. 2022 Nov 21;12:1017864. doi: 10.3389/fonc.2022.1017864. eCollection 2022. Front Oncol. 2022. PMID: 36479068 Free PMC article.

5

Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.

Xian F, Ren D, Bie J, Xu G. Xian F, et al. Front Immunol. 2023 Apr 17;14:1119168. doi: 10.3389/fimmu.2023.1119168. eCollection 2023. Front Immunol. 2023. PMID: 37138876 Free PMC article.

6

The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.

Xian F, Zhao C, Huang C, Bie J, Xu G. Xian F, et al. Medicine (Baltimore). 2023 Sep 8;102(36):e35038. doi: 10.1097/MD.0000000000035038. Medicine (Baltimore). 2023. PMID: 37682144 Free PMC article. Review.

7

Efficacy and safety of PD1/PDL1 inhibitors combined with radiotherapy and antiangiogenic drugs for hepatocellular carcinoma: a systematic review and meta-analysis.

Xian F, Wu J, Yuan YL, Bie J, Xu GH. Xian F, et al. Eur Rev Med Pharmacol Sci. 2023 Feb;27(4):1494-1502. doi: 10.26355/eurrev_202302_31390. Eur Rev Med Pharmacol Sci. 2023. PMID: 36876689 Free article.

8

Efficacy and safety of PD1/PDL1 inhibitors combined with radiotherapy and anti-angiogenic therapy for solid tumors: A systematic review and meta-analysis.

Xian F, Wu J, Zhong L, Xu G. Xian F, et al. Medicine (Baltimore). 2023 Mar 10;102(10):e33204. doi: 10.1097/MD.0000000000033204. Medicine (Baltimore). 2023. PMID: 36897735 Free PMC article.

9

Predicting 1 year readmission for heart failure: A comparative study of machine learning and the LACE index.

Song X, Tong Y, Xian F, Luo Y, Tong R. Song X, et al. Among authors: xian f. ESC Heart Fail. 2024 Oct;11(5):2648-2660. doi: 10.1002/ehf2.14855. Epub 2024 May 22. ESC Heart Fail. 2024. PMID: 38778700 Free PMC article.

10

Established machine learning models to predict readmission for elderly patients with ischemic heart disease.

Song X, Xian F, Zhu C, Luo Y, Liu Y, Wen Q, Tong R. Song X, et al. Among authors: xian f. Kardiol Pol. 2024;82(9):861-869. doi: 10.33963/v.phj.101308. Epub 2024 Jul 8. Kardiol Pol. 2024. PMID: 38973433 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters